Ting Deng

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Adjuvant sandwich therapy is associated with improved survival in stage III-IVA endometrial cancer: a network meta-analysis.

Adjuvant sandwich therapy is associated with improved survival in stage III-IVA endometrial cancer: a network meta-analysis.

Journal: Journal of gynecologic oncology

Published: September 01, 2025

Nanoformulation-enabled CDDP/ICG combination for synergistic chemotherapy and photothermal therapy of ovarian cancer.

Nanoformulation-enabled CDDP/ICG combination for synergistic chemotherapy and photothermal therapy of ovarian cancer.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: July 24, 2025

Adverse Event Management in Patients with Platinum-Resistant Ovarian Cancer Treated with Niraparib and Anlotinib: Updates from the Phase II, Multi-Center ANNIE Study.

Adverse Event Management in Patients with Platinum-Resistant Ovarian Cancer Treated with Niraparib and Anlotinib: Updates from the Phase II, Multi-Center ANNIE Study.

Journal: Therapeutics and clinical risk management

Published: March 31, 2025

Comprehensive Multiomics Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies.

Comprehensive Multiomics Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies.

Journal: Cancer research

Published: January 12, 2025

What is the impact of perineural invasion on the prognosis of cervical cancer: a systematic review and meta-analysis.

What is the impact of perineural invasion on the prognosis of cervical cancer: a systematic review and meta-analysis.

Journal: BMC cancer

Published: April 26, 2024

Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy.

Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy.

Journal: Discover oncology

Published: May 09, 2023

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer.

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: February 11, 2023

Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study.

Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study.

Journal: The Lancet. Digital health

Published: November 13, 2022

A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.

A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.

Journal: Journal of gynecologic oncology

Published: October 30, 2022

A novel combination of niraparib and anlotinib in platinum-resistant ovarian cancer: Efficacy and safety results from the phase II, multi-center ANNIE study.

A novel combination of niraparib and anlotinib in platinum-resistant ovarian cancer: Efficacy and safety results from the phase II, multi-center ANNIE study.

Journal: EClinicalMedicine

Published: August 05, 2022

Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer.

Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer.

Journal: Frontiers in immunology

Published: August 31, 2021

The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer.

The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer.

Journal: Journal of gynecologic oncology

Published: October 14, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026